Latest Lead News

James Hardie Industries posted a 64% jump in Q1 FY27 net sales to $1.475 billion, powered by the AZEK acquisition and solid organic growth. The company exceeded EBITDA guidance and raised its full-year outlook, targeting robust sales and cash flow growth amid cautious housing market assumptions.

Harris Technology’s refurbished tech division surpassed $1 million in monthly sales for the first time in July 2026, nearly doubling year-on-year revenue and becoming the company’s main earnings driver.

Challenger Gold has completed an A$85 million equity raise backed by key insiders and appointed a new leadership team to drive its transition from exploration to development at Hualilan and El Guayabo.

ReNerve has secured marketing approval for its NervAlign® Nerve Cuff in the Philippines, tapping into a major Southeast Asian market with significant nerve injury demand.

Clarity Pharmaceuticals has presented compelling clinical evidence that its investigational 64Cu-SAR-bisPSMA diagnostic and 67Cu-SAR-bisPSMA therapeutic candidates outperform current standards in prostate cancer care, positioning the company for regulatory and commercial milestones.

Argent BioPharma's licensing partner Splash Beverage Group has launched the US veterinary development program for CannEpil®, targeting companion-animal oncology and chronic pain. Led by industry veteran Dr Hunter Land, the initiative follows a defined FDA regulatory pathway and could broaden CannEpil®’s commercial footprint beyond human neurology.

Acrux Limited spotlighted its Female Testosterone Metered Dose Transdermal System (MDTS) at the Bioshares Biotech Summit, revealing positive Phase II data and outlining a clear regulatory and commercial roadmap targeting Hypoactive Sexual Desire Disorder (HSDD) in women.

Integral Diagnostics has installed Jason Martinez as its new CEO, marking a leadership change as the company prepares to present its FY26 results. Martinez brings over 20 years of diagnostic imaging experience and aims to drive growth and innovation following the retirement of long-serving CEO Ian Kadish.

Barton Gold has wrapped up an intensive 39,000m Phase 2 drilling campaign at its Tunkillia Gold Project, aiming to upgrade resource classifications ahead of a Pre-Feasibility Study due in Q1 2027. Early assay results suggest potential for improved grade and resource size, underpinning robust project economics.

Hammer Metals has released final assay results from its Kalman drilling program, revealing thick, high-grade copper-gold-molybdenum-rhenium mineralisation and confirming Blackrock's copper-gold potential near the Barkly Highway.

Black Bear Minerals’ re-analysis of historic drill core at Texas’s Shafter Silver Project reveals up to 147% higher silver grades and confirms polymetallic potential, prompting an expanded resource review and plans for a JORC upgrade.

REA Group Ltd (ASX:REA) posted a robust FY26 with revenue up 7% to A$1.793 billion and core net profit rising 15% to A$682 million, supported by record audience engagement and strategic AI investments.